보고서 요약(국문)

개요
글로벌 유전자 발현 분석 시장은 2022년 45억 달러 규모에 도달했으며, 2023년부터 2030년까지 연평균 8.7%의 성장률로 2030년에는 86억 달러에 이를 것으로 예상됩니다.
유전자 발현 분석은 유전자가 전사되어 기능성 유전자 산물, 기능성 RNA, 또는 단백질 산물을 합성하는 방식을 연구하는 분야입니다. 유전자 조절 연구는 세포 분화와 같은 정상적인 세포 과정과 비정상적이거나 병리학적인 과정에 대한 통찰력을 제공합니다. 유전자 발현 분석은 정상적인 생물학적 과정과 질병 과정에서 차등 유전자 발현의 역할, 그리고 바이오마커 특징을 식별하고 검증하는 데 중요한 정보를 제공합니다.
실시간 PCR은 차등 유전자 발현 프로파일을 검증하는 데 있어 표준 기술로 여겨집니다. 차세대 시퀀싱을 이용한 전사체 시퀀싱은 가설에 구애받지 않는 접근 방식을 통해 차등 발현 유전자를 발견할 수 있도록 합니다. 유전자 발현 프로파일링 기술의 발전은 더 나은 결과를 가져오고 있습니다.

또한, 레이저 캡처 미세절단(LCM) 및 마이크로어레이 기술은 유전자 발현 연구에 차세대 혁명을 가져오고 있습니다. 인공지능과 머신러닝의 통합은 알고리즘이 전체 과정에서 정확한 데이터를 제공하도록 학습되어 더 나은 결과를 제공합니다. 이러한 요소들이 향후 시장 성장을 견인할 것으로 예상됩니다.
시장 동향
기술 발전의 증가
NGS 및 분자 서비스와 같은 기술 발전이 가속화되면서 유전자 발현 서비스에 대한 수요가 증가하고 있습니다. 또한, 유전체 데이터베이스 개발, 유전체학 분야에 대한 정부 지원 확대, 그리고 개인 맞춤형 의학의 성장이 시장 성장을 촉진할 것으로 보입니다. 특히, 유전체학 분야에 대한 정부 지원 확대는 유전자 발현 분석 시장 성장의 주요 요인 중 하나입니다.
2023년 3월, 일루미나는 임상 차세대 염기서열 분석(NGS) 데이터에 대한 3차 분석을 제공하는 클라우드 기반 소프트웨어인 Connected Insights를 출시했습니다. Connected Insights는 NGS 애플리케이션 전반에 걸쳐 발견 속도에 맞춰 확장 가능한 완벽하게 통합된 소프트웨어 생태계를 구축하는 다음 단계입니다.

인공지능(AI) 통합
전유전체 시퀀싱을 이용한 유전자 변이 분석, RNA 시퀀싱 및 마이크로어레이를 이용한 유전자 발현 분석을 통해 통계적 및 예측적 분석을 수행하는 AI/ML 알고리즘의 적용이 최근 주목받고 있으며, 이를 통해 더욱 정확하고 신뢰할 수 있는 유전자 프로파일링 결과를 얻을 수 있습니다. 유전자 발현 마이크로어레이 데이터 분석에서 머신러닝 기반 특징 선택 접근법, 예를 들어 유전자 선택 접근법은 필요한 유전자를 선별하는 데 도움을 줄 수 있습니다.
2023년 6월 1일, DNA 시퀀싱 및 어레이 기반 기술 분야의 글로벌 리더인 일루미나(Illumina Inc.)는 환자의 질병 유발 유전적 돌연변이를 전례 없는 정확도로 예측하는 새로운 인공지능(AI) 알고리즘인 PrimateAI-3D를 출시했습니다. PrimateAI-3D는 개인 맞춤형 유전체 의학의 성공적인 구현에 있어 중요한 과제를 해결하고 유전적 위험 예측의 정확도를 크게 향상시켰습니다.
유전자 발현 프로파일링의 높은 비용
시퀀싱과 관련된 높은 비용은 지난 10년간 시장 성장에 상당한 걸림돌이 되어 왔습니다. 2003년 인간 게놈 프로젝트(Human Genome Project)에서 최초로 인간 게놈 서열을 분석하는 데 약 27억 달러의 자금이 필요했습니다. 그러나 이후 유전체학 분야에서는 서열 분석 속도를 높이고 비용을 절감하는 것을 목표로 하는 여러 기술 발전이 이루어졌습니다.
미국 국립인간게놈연구소(NHGRI)는 수년간 여러 게놈 서열 분석 센터의 비용을 추적해 왔으며, 인간 게놈 프로젝트 이후 게놈 서열 분석 비용을 추정했습니다. 이 데이터를 바탕으로 NHGRI는 2006년에는 인간 게놈 서열 전체를 완성하는 데 2천만~2천5백만 달러 이상이 소요되었을 것으로 추정했지만, 2015년 말에는 고품질의 인간 게놈 서열 초안을 개발하는 데 드는 비용이 1,500달러 미만으로 떨어졌다고 예측했습니다. 전체 엑솜 서열을 생성하는 데 드는 비용은 일반적으로 1,000달러 미만이었습니다.

이 보고서에 대한 자세한 내용은 샘플을 요청하세요.
세그먼트 분석
글로벌 유전자 발현 분석 시장은 제품 유형, 기술, 응용 분야, 최종 사용자 및 지역별로 세분화됩니다.
RNA 시퀀싱 부문은 시장 점유율의 약 42.9%를 차지했습니다.
RNA 시퀀싱은 차세대 시퀀싱(NGS)과 인공지능(AI)을 활용하여 생물학적 샘플에서 RNA의 존재와 양을 밝히는 기술이므로 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 머신러닝 및 기타 기술 발전으로 유전자 발현 분석의 정확도가 향상되었습니다.
2023년 3월, 고처리량 RNA 시퀀싱 전문 스타트업인 로잔 소재 Alithea Genomics는 스위스 기술혁신재단(FIT)으로부터 50만 스위스프랑의 기술 성장 대출을 확보했습니다. RNA 시퀀싱은 생의학 연구에서 중요한 도구로, 과학자들이 유전자 발현을 조사하고, 새로운 바이오마커를 발견하고, 신약을 개발할 수 있도록 해줍니다. 알리시아 지노믹스는 자체 개발한 벌크 RNA 바코딩 및 시퀀싱(BRB-seq) 기술을 통해 이러한 문제를 해결하고자 합니다. 이 기술은 기존의 RNA-seq 샘플 준비 방식과 달리 단일 튜브에서 수천 개의 RNA 샘플을 시퀀싱할 수 있도록 준비합니다.
지역 분석
북미는 2022년 시장 점유율의 약 39.2%를 차지했습니다.
북미는 전 세계 유전자 발현 분석 시장을 주도하고 있으며, 미국이 시장 성장에 가장 큰 기여를 하고 있습니다. 미국은 다른 국가들에 비해 유전체 연구에 가장 많은 투자를 하고 있으며, 이는 전 세계 공공 자금의 40%에 해당합니다.
여러 국가의 시민과 납세자들은 이러한 연구에 많은 자금을 지원했으며, 연구 결과로 얻은 정보와 지식에 대한 접근성을 기대하고 있습니다. 모든 공공 자금 지원 연구에서 얻은 지식에 대한 접근성은 바람직하지만, 특히 사회 전반에 걸쳐 광범위한 영향을 미치고 공론화를 촉진하는 분야에서는 접근성이 필수적입니다. 이노베이트 UK는 영국의 유전체 분석 기술 생산 및 상용화 역량을 강화하는 장비에 대한 자본 투자를 지원하기 위해 최대 500만 파운드를 지원합니다.

일루미나(Illumina, Inc.), 퀘스트 다이애그노스틱스(Quest Diagnostics Incorporated), 바이오래드 래버러토리스(Bio-Rad Laboratories), 써모 피셔 사이언티픽(Thermo Fisher Scientific, Inc.), 애질런트 테크놀로지스(Agilent Technologies), 루미넥스(Luminex Corporation) 등 북미 지역의 주요 기업들이 시장을 주도하며 이 지역을 유전자 발현 분석 시장의 최대 점유율로 만들고 있습니다. 예를 들어, 일루미나는 2022년 1월 내슈빌 바이오사이언스(Nashville Biosciences LLC)와 대규모 유전체학을 통한 의약품 개발 증진 및 일루미나의 차세대 염기서열 분석(NGS) 기술을 활용한 선도적인 임상 유전체 자원 구축을 위한 다년간 계약을 발표했습니다.
COVID-19 영향 분석
2019년 말 발생한 COVID-19 팬데믹은 전 세계 산업, 특히 전 세계 유전자 발현 분석 시장에 전례 없는 어려움을 초래했습니다. 각국은 봉쇄, 공급망 차질, 경제 활동 감소에 직면했습니다. 2020년 초 팬데믹이 확산되면서 광범위한 봉쇄와 제한 조치가 시행되었고, 이는 전 세계 의료 혁신에 영향을 미쳤습니다. 코로나19 팬데믹은 전 세계 공급망을 심각하게 교란시켜 산업에 필요한 원자재 운송에 차질을 빚었습니다.
팬데믹 기간 동안 연구 개발 노력의 초점이 코로나19 백신 및 치료제 개발에 집중되면서, 자원과 관심의 분산으로 인해 유전자 연구 개발 활동이 일시적으로 지연되었을 수 있습니다. 이는 임상 시험 완료 및 새로운 진단 절차와 치료법의 출시 지연으로 이어져 시장에 영향을 미쳤습니다.

제품 유형별
• 기기
o PCR(중합효소 연쇄 반응)
o NGS(차세대 염기서열 분석)
o 마이크로어레이
o 기타
• 서비스
• 기타
기술별
• RNA 발현
o PCR
o RNA 염기서열 분석
o 노던 블롯팅
o DNA 마이크로어레이
o 기타
• 프로모터 분석
o 겔 시프트 분석
o 크로마틴 면역침전법
o 시험관 내 전사 분석
o 기타
• 단백질 발현 및 번역 후 변형 발현
o 면역 분석법
o 질량 분석법
o 웨스턴 블롯팅
o 2D 겔 전기영동
o 기타
• 기타
응용 분야별
• 신약 개발 및 연구
• 임상 진단
• 생명공학 및 미생물학
• 기타
최종 사용자별
• 생명공학 및 제약 회사
• 진단 연구소
• 학술 연구 센터
• 연구 위탁 기관
• 기타
지역별
• 북부 • 아메리카
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 스페인
o 이탈리아
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
주요 개발 사항
• 단일 세포 및 공간 생물학 분야의 선도 기업인 10x Genomics, Inc.는 2023년 5월 Visium CytAssist의 공간 분석 기능을 확장하는 새로운 Visium CytAssist 유전자 및 단백질 발현 제품의 상용화를 발표했습니다. 이 제품을 통해 연구원들은 동일한 포르말린 고정 파라핀 포매(FFPE) 조직 절편에서 고해상도 공간 해상도로 고도로 다중화된 단백질 및 전체 전사체 RNA 데이터를 동시에 매핑할 수 있습니다.

• 2023년 6월 1일, DNA 시퀀싱 및 어레이 기반 기술 분야의 글로벌 리더인 일루미나(Illumina Inc.)는 환자의 질병 유발 유전자 변이를 전례 없는 정확도로 예측하는 인공지능(AI) 알고리즘인 PrimateAI-3D를 출시했습니다. PrimateAI-3D는 개인 맞춤형 유전체 의학의 성공적인 구현에 있어 중요한 과제를 해결하며, 유전적 위험 예측의 정확도를 크게 향상시켰습니다.
경쟁 환경
유전자 발현 분석 시장의 주요 글로벌 기업으로는 QIAGEN, Merck KGaA, Genscript Biotech Corporation, Bio-Rad Laboratories, Takara Bio Inc., Thermo Fisher Scientific, Inc., Promega Corporation, Agilent Technologies, Lonza Group Ltd., New England Biolabs Inc. 등이 있습니다.
보고서 구매 이유

• 제품 유형, 기술, 응용 분야, 최종 사용자 및 지역별 글로벌 유전자 발현 분석 시장 세분화 현황을 시각화하고 주요 기업 및 사업자를 파악하기 위함입니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴하기 위함입니다.

• 모든 세그먼트를 포함한 유전자 발현 분석 시장 수준의 다양한 데이터 포인트가 담긴 엑셀 데이터 시트.

• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석이 담긴 PDF 보고서.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 엑셀 파일 제공.
글로벌 유전자 발현 분석 시장 보고서는 약 53개의 표, 54개의 그림, 195페이지 분량으로 구성됩니다.
주요 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 연구 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Gene Expression Analysis Market reached US$ 4.5 billion in 2022 and is expected to reach US$ 8.6 billion by 2030 growing with a CAGR of 8.7% during the forecast period 2023-2030.
Gene expression analysis is the study of how genes are transcribed to synthesize functional gene products, functional RNA species, or protein products. The study of gene regulation provides insights into normal cellular processes, such as differentiation and abnormal or pathological processes. Gene expression analysis provides valuable insight into the role of differential gene expression in normal biological and disease processes and in the identification and verification of biomarker signatures.
Real-time PCR is the gold-standard technique for the verification of differential gene expression profiles. Transcriptome sequencing by next-generation sequencing enables the discovery of differentially expressed genes using a hypothesis-neutral approach. The advancements in gene expression profiling lead to better outcomes.
Furthermore, the Laser capture microdissection (LCM) and microarray technology are providing the next revolution in the study of gene expression. Integration of artificial intelligence and machine learning give better outcomes as the logarithms are trained to provide accurate data during the entire procedure. These are the factors which are expected to drive the market in the forthcoming period.
Dynamics
Rising Technological Advancements
The growing technological advancements such as NGS and molecular services are boosting the demand for gene expression services. Additionally, the development of genomic databases, increased government funding for genomics, and personalized medicine growth will likely drive the market. Increasing government funding for genomics is one of the major factors leading to the development of the gene expression analysis market.
In March 2023, Illumina released its new Connected Insights, cloud-based software that provides tertiary analysis for clinical next-generation sequencing (NGS) data. Connected Insights is the next step in creating a fully integrated software ecosystem that scales with the pace of discovery across NGS applications.
Integration of artificial intelligence (AI)
Application of AI/ML algorithms for statistical and predictive analyses using whole genome sequencing for gene variants, and RNA-seq and microarrays for gene expression is observed these days as the outcome is accurate and more reliable for profiling. In gene expression microarray data, machine learning-based feature selection approaches like gene selection approaches will help to select the required genes from the pool.
On June 1, 2023, Illumina Inc., a global leader in DNA sequencing and array-based technologies, launched the new PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts with unprecedented accuracy disease-causing genetic mutations in patients. PrimateAI-3D addresses a critical challenge facing the successful implementation of personalized genomic medicine. It also greatly improved the accuracy of genetic risk prediction.
High Costs of Gene Expression Profiling
The high cost associated with sequencing posed a significant challenge to market growth in the last decade. In 2003, the first human genome sequenced by the Human Genome Project required ~USD 2.7 billion in funding. However, several technological developments have taken place in the field of genomics, which were aimed at increasing the speed and reducing the expenses associated with sequencing.
The NHGRI (National Human Genome Research Institute, US) has tracked the sequencing costs at its various funded genome sequencing centers for many years and estimated the cost of genome sequencing in the years following the Human Genome Project. Based on this data, the NHGRI estimated that in 2006, it would have likely cost over USD 20–25 million to generate a finished human genome sequence, while by late 2015, the price to develop a high-quality whole human genome sequence draft had fallen below USD 1,500. The cost to generate a whole-exome sequence was generally below USD 1,000.
For more details on this report – Request for Sample
Segment Analysis
The global gene expression analysis market is segmented based on product type, technique, application, end-user and region.
The RNA Sequencing Segment Accounted for Approximately 42.9% of the Market Share
RNA Sequencing is expected to hold the largest market share as the technique uses next-generation sequencing (NGS), AI to reveal the presence and quantity of RNA in a biological sample. With the advent of machine learning and other technological advancements, gene expression analysis accuracy has increased.
In March 2023, Alithea Genomics, a Lausanne-based start-up that specializes in high-throughput RNA sequencing, secured a CHF 500,000 Tech Growth loan from the Foundation for Technological Innovation (FIT). RNA sequencing is a valuable tool in biomedical research, allowing scientists to examine gene expression, discover new biomarkers, and develop new drugs. Alithea Genomics aims to address this challenge with its proprietary technology, Bulk RNA Barcoding followed by sequencing (BRB-seq), which can prepare thousands of RNA samples for sequencing in a single tube, unlike standard RNA-seq sample preparation
Geographical Analysis
North America accounted for Approximately 39.2% of the Market Share in 2022
North America is dominating the global gene expression analysis market, with the United States accounting as the major contributor to the market. The United States spends the most compared to other countries on genomics research, corresponding to 40% of worldwide public funding.
Citizens and taxpayers of several countries have funded much of the research and have expectations about access to the resulting information and knowledge. While access to knowledge gained from all publicly funded research is desired, access is essential for fields that have a broad social impact and stimulate public dialogue. Innovate UK has up to £5 million to support capital investment in equipment that increases the UK’s capacity to produce and commercialize genomic analysis technologies.
Most of the major key players are based in North America such as Illumina, Inc., Quest Diagnostics Incorporated, Bio-Rad Laboratories, Thermo Fisher Scientific, Inc., Agilent Technologies, Luminex Corporation, etc. are contributing to making this region the largest shareholder in gene expression analysis market. For instance, in Jan 2022, Illumina Inc. announced a multi-year agreement with Nashville Biosciences LLC to increase medicines development via large-scale genomics and also the formation of clinical-genomic resource that is pre-eminent with the help of Illumina's next-generation sequencing (NGS)
COVID-19 Impact Analysis
The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global gene expression analysis market, as countries grappled with lockdowns, supply chain disruptions, and reduced economic activity. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting healthcare innovations worldwide. The COVID-19 pandemic severely disrupted global supply chains, affecting the transportation of raw materials to industries.
The focus of research and development efforts shifted during the pandemic, with a significant emphasis on developing vaccines and treatments for COVID-19. This diversion of resources and attention may have temporarily impacted the progress of genetic research and development activities. This has led to delays in the completion of trials and the availability of new diagnostic procedures and therapies, which has affected the market.
By Product Type
• Instruments
o PCR (Polymerase Chain Reaction)
o NGS (Next Gen Sequencing)
o Microarray
o Others
• Services
• Others
By Technique
• RNA Expression
o PCR
o RNA Sequencing
o Northern Blotting
o DNA Microarrays
o Others
• Promotor Analysis
o Gel Shift Assays
o Chromatin Immunoprecipitation
o In Vitro transcription Run on Assays
o Others
• Protein Expression & Post Translational Modification Expression
o Immunoassays
o mass spectrometry
o Western Blotting
o 2D gel Electrophoresis
o Others
• Others
By Application
• Drug Discovery and Development
• Clinical Diagnostics
• Biotechnology and Microbiology
• Others
By End User
• Biotechnology & Pharmaceutical Companies
• Diagnostic Laboratories
• Academic Research Centers
• Contract Research Organisation
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Key Developments
• In May 2023, 10x Genomics, Inc., a leader in single cell and spatial biology, announced today the commercial availability of a new Visium CytAssist Gene and Protein Expression product to expand the breadth of the Visium CytAssist spatial analysis capabilities. It enables researchers to simultaneously produce highly multiplexed protein and whole transcriptome RNA data mapped together from the same formalin-fixed, paraffin-embedded (FFPE) tissue section at high spatial resolution.
• On June 1, 2023, Illumina Inc., a global leader in DNA sequencing and array-based technologies, launched the new PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts with unprecedented accuracy disease-causing genetic mutations in patients. PrimateAI-3D addresses a critical challenge facing the successful implementation of personalized genomic medicine. It also greatly improved the accuracy of genetic risk prediction.
Competitive Landscape
The major global players in the gene expression analysis market include QIAGEN, Merck KGaA, Genscript Biotech Corporation, Bio-Rad Laboratories, Takara Bio Inc., Thermo Fisher Scientific, Inc., Promega Corporation, Agilent Technologies, Lonza Group Ltd., New England Biolabs Inc. among others.
Why Purchase the Report?
• To visualize the global gene expression analysis segmentation based on product type, technique, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of gene expression analysis market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global gene expression analysis market report would provide approximately 53 tables, 54 figures, and 195 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Technique
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Technological Advancements
4.1.1.2. Integration of artificial intelligence (AI)
4.1.2. Restraints
4.1.2.1. High Costs of Gene Expression Profiling
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Instruments
7.2.1. PCR (Polymerase Chain Reaction)
7.2.2. NGS (Next Gen Sequencing)
7.2.3. Microarray
7.2.4. Others
7.3. Services
7.4. Others
8. By Technique
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
8.1.2. Market Attractiveness Index, By Technique
8.2. RNA Expression
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.2.3. RNA Sequencing
8.2.4. Northern Blotting
8.2.5. DNA Microarrays
8.2.6. Others
8.3. Promotor Analysis
8.3.1. Gel Shift Assays
8.3.2. Chromatin Immunoprecipitation
8.3.3. In Vitro transcription Run on Assays
8.4. Protein Expression & Post Translational Modification Expression
8.4.1. Immunoassays
8.4.2. mass spectrometry
8.4.3. Western Blotting
8.4.4. 2D gel Electrophoresis
8.4.5. Others
8.5. Others
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Drug Discovery and Development
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Clinical Diagnostics
9.4. Biotechnology and Microbiology
9.5. Others
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Biotechnology & Pharmaceutical Companies
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Diagnostic Laboratories
10.4. Academic Research Centers
10.5. Contract Research Organisation
10.6. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.6.1. U.S.
11.2.6.2. Canada
11.2.6.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.6.1. Germany
11.3.6.2. UK
11.3.6.3. France
11.3.6.4. Italy
11.3.6.5. Spain
11.3.6.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. QIAGEN
13.1.1. Company Overview
13.1.2. Product Type Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Merck KGaA
13.3. Genscript Biotech Corporation
13.4. Bio-Rad Laboratories
13.5. Takara Bio Inc.
13.6. Thermo Fisher Scientific, Inc.
13.7. Promega Corporation
13.8. Agilent Technologies
13.9. Lonza Group Ltd.
13.10. New England Biolabs Inc.
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

QIAGEN, 4.	Key Developments, Merck KGaA, Genscript Biotech Corporation, Bio-Rad Laboratories, Takara Bio Inc., Thermo Fisher Scientific, Inc., Promega Corporation, Agilent Technologies, Lonza Group Ltd., New England Biolabs Inc.

표 목록 (Tables)

List of Tables

Table 1 Global Gene Expression Analysis Market Value, By Product Type, 2023, 2027 & 2031 (US$ Billion)

Table 2 Global Gene Expression Analysis Market Value, By Technique, 2023, 2027 & 2031 (US$ Billion)

Table 3 Global Gene Expression Analysis Market Value, By Application, 2023, 2027 & 2031 (US$ Billion)

Table 4 Global Gene Expression Analysis Market Value, By End-User, 2023, 2027 & 2031 (US$ Billion)

Table 5 Global Gene Expression Analysis Market Value, By Region, 2023, 2027 & 2031 (US$ Billion)

Table 6 Global Gene Expression Analysis Market Value, By Product Type , 2023, 2027 & 2031 (US$ Billion)

Table 7 Global Gene Expression Analysis Market Value, By Product Type , 2022-2031 (US$ Billion)

Table 8 Global Gene Expression Analysis Market Value, By Technique, 2023, 2027 & 2031 (US$ Billion)

Table 9 Global Gene Expression Analysis Market Value, By Technique, 2022-2031 (US$ Billion)

Table 10 Global Gene Expression Analysis Market Value, By Application, 2023, 2027 & 2031 (US$ Billion)

Table 11 Global Gene Expression Analysis Market Value, By Application, 2022-2031 (US$ Billion)

Table 12 Global Gene Expression Analysis Market Value, By End-User, 2023, 2027 & 2031 (US$ Billion)

Table 13 Global Gene Expression Analysis Market Value, By End-User, 2022-2031 (US$ Billion)

Table 14 Global Gene Expression Analysis Market Value, By Region, 2023, 2027 & 2031 (US$ Billion)

Table 15 Global Gene Expression Analysis Market Value, By Region, 2022-2031 (US$ Billion)

Table 16 North America Gene Expression Analysis Market Value, By Product Type, 2022-2031 (US$ Billion)

Table 17 North America Gene Expression Analysis Market Value, By Technique, 2022-2031 (US$ Billion)

Table 18 North America Gene Expression Analysis Market Value, By Application, 2022-2031 (US$ Billion)

Table 19 North America Gene Expression Analysis Market Value, By End-User, 2022-2031 (US$ Billion)

Table 20 North America Gene Expression Analysis Market Value, By Country, 2022-2031 (US$ Billion)

Table 21 South America Gene Expression Analysis Market Value, By Product Type, 2022-2031 (US$ Billion)

Table 22 South America Gene Expression Analysis Market Value, By Technique, 2022-2031 (US$ Billion)

Table 23 South America Gene Expression Analysis Market Value, By Application, 2022-2031 (US$ Billion)

Table 24 South America Gene Expression Analysis Market Value, By End-User, 2022-2031 (US$ Billion)

Table 25 South America Gene Expression Analysis Market Value, By Country, 2022-2031 (US$ Billion)

Table 26 Europe Gene Expression Analysis Market Value, By Product Type, 2022-2031 (US$ Billion)

Table 27 Europe Gene Expression Analysis Market Value, By Technique, 2022-2031 (US$ Billion)

Table 28 Europe Gene Expression Analysis Market Value, By Application, 2022-2031 (US$ Billion)

Table 29 Europe Gene Expression Analysis Market Value, By End-User, 2022-2031 (US$ Billion)

Table 30 Europe Gene Expression Analysis Market Value, By Country, 2022-2031 (US$ Billion)

Table 31 Asia-Pacific Gene Expression Analysis Market Value, By Product Type , 2022-2031 (US$ Billion)

Table 32 Asia-Pacific Gene Expression Analysis Market Value, By Technique, 2022-2031 (US$ Billion)

Table 33 Asia-Pacific Gene Expression Analysis Market Value, By Application, 2022-2031 (US$ Billion)

Table 34 Asia-Pacific Gene Expression Analysis Market Value, By End-User, 2022-2031 (US$ Billion)

Table 35 Asia-Pacific Gene Expression Analysis Market Value, By Country, 2022-2031 (US$ Billion)

Table 36 Middle East & Africa Gene Expression Analysis Market Value, By Product Type, 2022-2031 (US$ Billion)

Table 37 Middle East & Africa Gene Expression Analysis Market Value, By Technique, 2022-2031 (US$ Billion)

Table 38 Middle East & Africa Gene Expression Analysis Market Value, By Application, 2022-2031 (US$ Billion)

Table 39 Middle East & Africa Gene Expression Analysis Market Value, By End-User, 2022-2031 (US$ Billion)

Table 40 QIAGEN: Overview

Table 41 QIAGEN: Product Portfolio

Table 42 QIAGEN: Key Developments

Table 43 Merck KGaA: Overview

Table 44 Merck KGaA: Product Portfolio

Table 45 Merck KGaA: Key Developments

Table 46 Genscript Biotech Corporation: Overview

Table 47 Genscript Biotech Corporation: Product Portfolio

Table 48 Genscript Biotech Corporation: Key Developments

Table 49 Bio-Rad Laboratories: Overview

Table 50 Bio-Rad Laboratories: Product Portfolio

Table 51 Bio-Rad Laboratories: Key Developments

Table 52 Takara Bio Inc.: Overview

Table 53 Takara Bio Inc.: Product Portfolio

Table 54 Takara Bio Inc.: Key Developments

Table 55 Thermo Fisher Scientific, Inc.: Overview

Table 56 Thermo Fisher Scientific, Inc.: Product Portfolio

Table 57 Thermo Fisher Scientific, Inc.: Key Developments

Table 58 Promega Corporation: Overview

Table 59 Promega Corporation: Product Portfolio

Table 60 Promega Corporation: Key Developments

Table 61 Agilent Technologies: Overview

Table 62 Agilent Technologies: Product Portfolio

Table 63 Agilent Technologies: Key Developments

Table 64 Lonza Group Ltd.: Overview

Table 65 Lonza Group Ltd.: Product Portfolio

Table 66 Lonza Group Ltd.: Key Developments

Table 67 New England Biolabs Inc.: Overview

Table 68 New England Biolabs Inc.: Product Portfolio

Table 69 New England Biolabs Inc.: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 2 Global Gene Expression Analysis Market Share, By Product Type, 2022 & 2031 (%)

Figure 3 Global Gene Expression Analysis Market Share, By Technique, 2022 & 2031 (%)

Figure 4 Global Gene Expression Analysis Market Share, By Application, 2022 & 2031 (%)

Figure 5 Global Gene Expression Analysis Market Share, By End-User, 2022 & 2031 (%)

Figure 6 Global Gene Expression Analysis Market Share, By Region, 2022 & 2031 (%)

Figure 7 Global Gene Expression Analysis Market Y-o-Y Growth, By Product Type, 2022-2031 (%)

Figure 8 Instruments Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 9 Services Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 10 Others Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 11 Global Gene Expression Analysis Market Y-o-Y Growth, By Technique, 2022-2031 (%)

Figure 12 RNA Expression Technique in Global Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 13 Promotor Analysis Technique in Global Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 14 Protein Expression & Post Translational Modification Expression Technique in Global Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 15 Others Technique in Global Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 16 Global Gene Expression Analysis Market Y-o-Y Growth, By Application, 2022-2031 (%)

Figure 17 Drug Discovery and Development Application in Global Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 18 Clinical Diagnostics Application in Global Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 19 Biotechnology and Microbiology Application in Global Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 20 Others Application in Global Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 21 Global Gene Expression Analysis Market Y-o-Y Growth, By End-User, 2022-2031 (%)

Figure 22 Biotechnology & Pharmaceutical Companies End-User in Global Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 23 Diagnostic Laboratories End-User in Global Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 24 Academic Research Centers End-User in Global Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 25 Contract Research Organisation End-User in Global Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 26 Others End-User in Global Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 27 Global Gene Expression Analysis Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 28 North America Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 29 Asia-Pacific Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 30 Europe Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 31 South America Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 32 Middle East and Africa Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 33 North America Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 34 North America Gene Expression Analysis Market Share, By Product Type, 2022 & 2031 (%)

Figure 35 North America Gene Expression Analysis Market Share, By Technique, 2022 & 2031 (%)

Figure 36 North America Gene Expression Analysis Market Share, By Application, 2022 & 2031 (%)

Figure 37 North America Gene Expression Analysis Market Share, By End-User, 2022 & 2031 (%)

Figure 38 North America Gene Expression Analysis Market Share, By Country, 2022 & 2031 (%)

Figure 39 South America Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 40 South America Gene Expression Analysis Market Share, By Product Type, 2022 & 2031 (%)

Figure 41 South America Gene Expression Analysis Market Share, By Technique, 2022 & 2031 (%)

Figure 42 South America Gene Expression Analysis Market Share, By Application, 2022 & 2031 (%)

Figure 43 South America Gene Expression Analysis Market Share, By End-User, 2022 & 2031 (%)

Figure 44 South America Gene Expression Analysis Market Share, By Country, 2022 & 2031 (%)

Figure 45 Europe Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 46 Europe Gene Expression Analysis Market Share, By Product Type, 2022 & 2031 (%)

Figure 47 Europe Gene Expression Analysis Market Share, By Technique, 2022 & 2031 (%)

Figure 48 Europe Gene Expression Analysis Market Share, By Application, 2022 & 2031 (%)

Figure 49 Europe Gene Expression Analysis Market Share, By End-User, 2022 & 2031 (%)

Figure 50 Europe Gene Expression Analysis Market Share, By Country, 2022 & 2031 (%)

Figure 51 Asia-Pacific Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 52 Asia-Pacific Gene Expression Analysis Market Share, By Product Type, 2022 & 2031 (%)

Figure 53 Asia-Pacific Gene Expression Analysis Market Share, By Technique, 2022 & 2031 (%)

Figure 54 Asia-Pacific Gene Expression Analysis Market Share, By Application, 2022 & 2031 (%)

Figure 55 Asia-Pacific Gene Expression Analysis Market Share, By End-User, 2022 & 2031 (%)

Figure 56 Asia-Pacific Gene Expression Analysis Market Share, By Country, 2022 & 2031 (%)

Figure 57 Middle East & Africa Gene Expression Analysis Market Value, 2022-2031 (US$ Billion)

Figure 58 Middle East & Africa Gene Expression Analysis Market Share, By Product Type, 2022 & 2031 (%)

Figure 59 Middle East & Africa Gene Expression Analysis Market Share, By Technique, 2022 & 2031 (%)

Figure 60 Middle East & Africa Gene Expression Analysis Market Share, By Application, 2022 & 2031 (%)

Figure 61 Middle East & Africa Gene Expression Analysis Market Share, By End-User, 2022 & 2031 (%)

Figure 62 QIAGEN: Financials

Figure 63 Merck KGaA: Financials

Figure 64 Genscript Biotech Corporation: Financials

Figure 65 Bio-Rad Laboratories: Financials

Figure 66 Takara Bio Inc.: Financials

Figure 67 Thermo Fisher Scientific, Inc.: Financials

Figure 68 Promega Corporation: Financials

Figure 69 Agilent Technologies: Financials

Figure 70 Lonza Group Ltd.: Financials

Figure 71 New England Biolabs Inc.: Financials

글로벌 유전자 발현 분석 시장 – 2023-2030

Global Gene Expression Analysis Market - 2023-2030